Caricamento...
Inhibition of histone deacetylases in cancer therapy: lessons from leukaemia
Histone deacetylases (HDACs) are a key component of the epigenetic machinery regulating gene expression, and behave as oncogenes in several cancer types, spurring the development of HDAC inhibitors (HDACi) as anticancer drugs. This review discusses new results regarding the role of HDACs in cancer a...
Salvato in:
| Pubblicato in: | Br J Cancer |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Nature Publishing Group
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4800301/ https://ncbi.nlm.nih.gov/pubmed/26908329 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2016.36 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|